eliminating ATTRItion with Data
A unique drug profiling platform that uncovers your unforseen side effects.
OUR TECHNOLOGY
Cheminformatics: Get the Data Advantage
Information that powers your clinical research, helps you avoid clinical holds and lowers your drug attrition rate is what we're all about.
Our goal is providing drug developers, biotech and pharmaceutical companies with unique polypharmacology and cheminformatics data that paves the way to your drug's approval.
To discover what our advanced Historeceptomics algorithm can uncover about the drug you're working on, read more or watch the demo.
OUR STORY
This Is Personal
We're scientists, just like you. So, we know what it's like to struggle in the dark, tilting at breakthrough windmills, missing as many times as we hit.
That's why, in 2015, we endeavored to do something about it, to bring order to the chaos and put dreaded drug attrition on notice.
With data.
Our user-friendly drug profiling platform, HistoReceptomics (histo-RE-cept-O-mics), makes you the smartest person in the room. Utilizing a proprietary algorithm, it analyzes cheminformatics properties and other data, such as polypharmacology, to accurately predict adverse effects of your drug (especially tissue-specific side effects), thereby preventing any nasty drug attrition surprises further along in your drug discovery process.
For a limited time, you can claim your no-risk, free trial of this valuable cheminformatics technology or watch our demo to learn how Historeceptomics can help you see more.
And let those breakthroughs begin.
“Information is the oil of the 21st century, and analytics is the combustion engine.”
Peter Sondergaard
ASK US ANYTHING:
GeneCentrix, Inc.
246 5th Avenue
New York, NY 10001
(248) 345-1247